Standard InChI: InChI=1S/C28H29N3O2/c1-19-9-8-10-20(2)27(19)31-28(33)25(17-22-18-29-24-14-7-6-13-23(22)24)30-26(32)16-15-21-11-4-3-5-12-21/h3-14,18,25,29H,15-17H2,1-2H3,(H,30,32)(H,31,33)
1.Jiang M, Peng L, Yang K, Wang T, Yan X, Jiang T, Xu J, Qi J, Zhou H, Qian N, Zhou Q, Chen B, Xu X, Deng L, Yang C.. (2019) Development of Small-Molecules Targeting Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Receptor Activator of Nuclear Factor-κB (RANK) Protein-Protein Interaction by Structure-Based Virtual Screening and Hit Optimization., 62 (11):[PMID:31082234][10.1021/acs.jmedchem.8b02027]
2.Jiang M, Peng L, Yang K, Wang T, Yan X, Jiang T, Xu J, Qi J, Zhou H, Qian N, Zhou Q, Chen B, Xu X, Deng L, Yang C.. (2019) Development of Small-Molecules Targeting Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Receptor Activator of Nuclear Factor-κB (RANK) Protein-Protein Interaction by Structure-Based Virtual Screening and Hit Optimization., 62 (11):[PMID:31082234][10.1021/acs.jmedchem.8b02027]
3.Jiang M, Peng L, Yang K, Wang T, Yan X, Jiang T, Xu J, Qi J, Zhou H, Qian N, Zhou Q, Chen B, Xu X, Deng L, Yang C.. (2019) Development of Small-Molecules Targeting Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Receptor Activator of Nuclear Factor-κB (RANK) Protein-Protein Interaction by Structure-Based Virtual Screening and Hit Optimization., 62 (11):[PMID:31082234][10.1021/acs.jmedchem.8b02027]